Mintz, Levin, Cohn, Ferris, Glovsky & Popeo, P.C. announced that Antony Nash has joined the firm as a Member in the Litigation Practice. He is based in the firm’s San Diego office. Prior to joining Mintz Levin Mr. Nash was a partner with McKenna, Long & Aldridge. More >>
Tags: Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. | San DiegoMintz Levin Further Bolsters IP Practice and West Coast Presence with Addition of Kenneth E. Jenkins
Continuing the expansion of its Intellectual Property Practice and life sciences capabilities, Mintz, Levin, Cohn, Ferris, Glovsky & Popeo, P.C. announced that Kenneth E. Jenkins has joined the firm as a Member in San Diego. He comes to Mintz Levin from Kilpatrick Townsend & Stockton, where he served as Managing Partner of the San Diego office. More >>
Tags: Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. | San DiegoVolcano to be Acquired by Philips for $1.2 Billion
Isis Pharmaceuticals Completes Rule 144A Offering of $500 Million of Convertible Senior Notes
Procter & Gamble sells Duracell to Berkshire Hathaway for $2.9 billion
Jones Day is advising The Procter & Gamble Company (“P&G”) in the sale of its Duracell personal power business to Berkshire Hathaway Inc. for $2.9 billion. Following the sale of P&G’s interest in its Nanfu joint venture, which operated P&G’s battery business in China, P&G entered into a Transaction Agreement on November 13, 2014 with Berkshire Hathaway Inc. and certain of its affiliates under which P&G will transfer its Duracell business to Berkshire Hathaway in a private split-off transaction. In this unusual tax-free structure (sometimes referred to as a “cash rich private split”), P&G will convey its Duracell business (which will be infused with $1.8 billion in additional cash) to a newly formed subsidiary (SplitCo) and will exchange its shares in SplitCo for approximately $4.7 billion of outstanding P&G shares currently held by the Berkshire Hathaway group. The transaction is expected to close in the second half of calendar year 2015. More >>
Tags: Atlanta | Chicago | Cleveland | Dallas | New York | San DiegoJones Day adds to Business and Tort Litigation Practice in California with arrival of four former prosecutors
The global law firm Jones Day has announced that four former prosecutors – including three Assistant U.S. Attorneys and a former Deputy District Attorney – have joined the Firm’s Business and Tort Litigation Practice in three different California offices. In San Diego, Truc Do and Peter Mazza have joined as partner and of counsel, respectively. In addition, Rasha Gerges Shields has joined Jones Day as a partner in Los Angeles and Cheryl O’Connor will join the firm on November 17 as a partner in Irvine. More >>
Tags: Jones Day | Irvine | Los Angeles | San DiegoKnobbe Martens Client Alios BioPharma Announces Acquisition Agreement with Johnson & Johnson for $1.75 Billion
Alios BioPharma, Inc., a biotechnology company developing proprietary therapeutics for viral diseases, announced on September 30, 2014 a definitive agreement with Johnson & Johnson whereby Alios will be acquired for approximately $1.75 billion in cash payable upon closing of the transaction. The transaction has been approved by the boards of directors of both companies. More >>
Tags: Knobbe Martens | San DiegoAmbit Biosciences to be Acquired by Daiichi Sankyo for $410 Million
Cooley is advising Ambit Biosciences on its agreement to be acquired by Daiichi Sankyo Company, Ltd. for approximately $315 million on a fully diluted basis. In addition to the upfront cash payment, each Ambit Biosciences stockholder will receive one Contingent Value Right (CVR), entitling the holder to receive an additional cash payment of up to $4.50 for each share they own if certain commercialization related milestones are achieved. The total transaction is valued at up to $410 million on a fully diluted basis. More >>
Tags: San DiegoHorizon Pharma Acquires Vidara Therapeutics and Enters Five-Year $300 Million Term Loan Facility
Cooley LLP announced today that it advised Horizon Pharma, Inc. on the completion of its acquisition of Vidara Therapeutics International plc. In connection with the acquisition, Horizon and Vidara have combined to form parent company Horizon Pharma plc, which is incorporated in Ireland. Concurrently with the acquisition, Horizon entered into a five-year $300 million term loan facility and related uncommitted facilities. More >>
Tags: San DiegoDLA Piper represents Pacific DataVision in equity raise and acquisition of spectrum licenses
DLA represented Pacific DataVision, Inc., a provider of mobile workforce management solutions, in a 144A offering of shares of its common stock worth US$218 million. The firm also represented Pacific DataVision in its US$100 million acquisition of FCC spectrum licenses from Sprint Corporation, as well as its licensing transaction of US$17.5 million by Motorola Solutions, Inc. More >>
Tags: DLA Piper | Chicago | New York | San Diego